These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 27486148)

  • 1. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
    Kennedy SH; Lam RW; McIntyre RS; Tourjman SV; Bhat V; Blier P; Hasnain M; Jollant F; Levitt AJ; MacQueen GM; McInerney SJ; McIntosh D; Milev RV; Müller DJ; Parikh SV; Pearson NL; Ravindran AV; Uher R;
    Can J Psychiatry; 2016 Sep; 61(9):540-60. PubMed ID: 27486148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.
    Lam RW; McIntosh D; Wang J; Enns MW; Kolivakis T; Michalak EE; Sareen J; Song WY; Kennedy SH; MacQueen GM; Milev RV; Parikh SV; Ravindran AV;
    Can J Psychiatry; 2016 Sep; 61(9):510-23. PubMed ID: 27486151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.
    Parikh SV; Quilty LC; Ravitz P; Rosenbluth M; Pavlova B; Grigoriadis S; Velyvis V; Kennedy SH; Lam RW; MacQueen GM; Milev RV; Ravindran AV; Uher R;
    Can J Psychiatry; 2016 Sep; 61(9):524-39. PubMed ID: 27486150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.
    Ravindran AV; Balneaves LG; Faulkner G; Ortiz A; McIntosh D; Morehouse RL; Ravindran L; Yatham LN; Kennedy SH; Lam RW; MacQueen GM; Milev RV; Parikh SV;
    Can J Psychiatry; 2016 Sep; 61(9):576-87. PubMed ID: 27486153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.
    Milev RV; Giacobbe P; Kennedy SH; Blumberger DM; Daskalakis ZJ; Downar J; Modirrousta M; Patry S; Vila-Rodriguez F; Lam RW; MacQueen GM; Parikh SV; Ravindran AV;
    Can J Psychiatry; 2016 Sep; 61(9):561-75. PubMed ID: 27486154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.
    MacQueen GM; Frey BN; Ismail Z; Jaworska N; Steiner M; Lieshout RJ; Kennedy SH; Lam RW; Milev RV; Parikh SV; Ravindran AV;
    Can J Psychiatry; 2016 Sep; 61(9):588-603. PubMed ID: 27486149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.
    Lam RW; Kennedy SH; Grigoriadis S; McIntyre RS; Milev R; Ramasubbu R; Parikh SV; Patten SB; Ravindran AV;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S26-43. PubMed ID: 19674794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.
    Ravindran AV; Lam RW; Filteau MJ; Lespérance F; Kennedy SH; Parikh SV; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S54-64. PubMed ID: 19666194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.
    Swainson J; McGirr A; Blier P; Brietzke E; Richard-Devantoy S; Ravindran N; Blier J; Beaulieu S; Frey BN; Kennedy SH; McIntyre RS; Milev RV; Parikh SV; Schaffer A; Taylor VH; Tourjman V; van Ameringen M; Yatham LN; Ravindran AV; Lam RW
    Can J Psychiatry; 2021 Feb; 66(2):113-125. PubMed ID: 33174760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management.
    Patten SB; Kennedy SH; Lam RW; O'Donovan C; Filteau MJ; Parikh SV; Ravindran AV;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S5-14. PubMed ID: 19674796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies.
    Kennedy SH; Milev R; Giacobbe P; Ramasubbu R; Lam RW; Parikh SV; Patten SB; Ravindran AV;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S44-53. PubMed ID: 19656575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
    McIntyre RS; Suppes T; Tandon R; Ostacher M
    J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Network for Mood and Anxiety Treatments (CANMAT) consensus recommendations for functional outcomes in major depressive disorder.
    Lam RW; Parikh SV; Michalak EE; Dewa CS; Kennedy SH
    Ann Clin Psychiatry; 2015 May; 27(2):142-9. PubMed ID: 25954941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
    Kennedy SH; Lam RW; Cohen NL; Ravindran AV;
    Can J Psychiatry; 2001 Jun; 46 Suppl 1():38S-58S. PubMed ID: 11441771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
    Rosenblat JD; Husain MI; Lee Y; McIntyre RS; Mansur RB; Castle D; Offman H; Parikh SV; Frey BN; Schaffer A; Greenway KT; Garel N; Beaulieu S; Kennedy SH; Lam RW; Milev R; Ravindran AV; Tourjman V; Ameringen MV; Yatham LN; Taylor V
    Can J Psychiatry; 2023 Jan; 68(1):5-21. PubMed ID: 35975555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
    Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
    Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.
    Dodd S; Mitchell PB; Bauer M; Yatham L; Young AH; Kennedy SH; Williams L; Suppes T; Lopez Jaramillo C; Trivedi MH; Fava M; Rush AJ; McIntyre RS; Thase ME; Lam RW; Severus E; Kasper S; Berk M
    World J Biol Psychiatry; 2018 Aug; 19(5):330-348. PubMed ID: 28984491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized antidepressant therapy in patients with major depressive disorder: Novel evidence-informed decision support tool.
    Chin T; Huyghebaert T; Svrcek C; Oluboka O
    Can Fam Physician; 2022 Nov; 68(11):807-814. PubMed ID: 36376052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study.
    Luo Y; Chaimani A; Kataoka Y; Ostinelli EG; Ogawa Y; Cipriani A; Salanti G; Furukawa TA
    BMJ Open; 2018 Dec; 8(12):e023222. PubMed ID: 30530583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.